NSC |
Compound |
Enrichment |
Correlation |
NSC 685687 |
1,2,5,6,9-Pentaazadicylopent[a,b]indene-3,4(2H,5H)-dione,2,5-diphenyl- |
0.0112425217758228 |
0.53596921 |
NSC 690271 |
ANTINEOPLASTIC-690271 |
0.0112425217758228 |
0.30210762 |
NSC 706190 |
6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- |
0.0112425217758228 |
0.32461367 |
NSC 722316 |
Null |
0.0112425217758228 |
0.27178682 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0112425217758228 |
0.49646593 |
NSC 737613 |
Null |
0.0112425217758228 |
0.27358109 |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
0.0112425217758228 |
0.41225715 |
NSC 741942 |
Null |
0.0112425217758228 |
0.55169587 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0112425217758229 |
0.34205224 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0112425217758229 |
0.43385307 |